» Articles » PMID: 30670716

Comprehensive CircRNA Expression Profile During Ischemic Postconditioning Attenuating Hepatic Ischemia/reperfusion Injury

Overview
Journal Sci Rep
Specialty Science
Date 2019 Jan 24
PMID 30670716
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Ischemic postconditioning (IPO) attenuates hepatic ischemia/reperfusion (I/R) injury. The aim of this study was to explore the role of circular RNAs (circRNAs) in the protective mechanism of IPO. In this study, microarray hybridization analysis was performed to determine the circRNA expression profile. Briefly, a total of 1599 dysregulated circRNAs were detected. The competitive endogenous RNA (ceRNA) network, including 6 circRNAs, 47 miRNAs and 90 mRNAs, indicated that the potential "housekeeping" function of circRNAs is dysregulated in hepatic I/R injury. Based on the validation results of selected circRNAs, miRNAs and mRNAs following qRT-PCR amplification, the mmu_circRNA_005186-miR-124-3p-Epha2 pathway was constructed. Dual-luciferase reporter analysis showed that miR-124-3p interacted directly with mmu_circRNA_005186 and Epha2 through the predicted binding sites, which suggested that mmu_circRNA_005186, serving as a miRNA sponge for miR-124-3p, regulated the expression of Epha2. Functionally, we explored the mechanism of mmu_circRNA_005186 in LPS-treated RAW264.7 cells which simulated the inflammation in hepatic I/R injury. We found that mmu_circRNA_005186 silencing attenuated the LPS-induced inflammation and was associated with miR-124-3p upregulation and Epha2 downregulation. Our study is the first to show that circRNAs are closely related to hepatic I/R injury and IPO and suggests that targeting mmu_circRNA_005186-miR-124-3p-Epha2 pathway might attenuate hepatic I/R injury.

Citing Articles

CircRNA-Phf21a_0002 promotes pyroptosis to aggravate hepatic ischemia/ reperfusion injury by sponging let-7b-5p.

Jiang P, Li X, Shen Y, Luo L, Wu B, Teng D Heliyon. 2024; 10(16):e34385.

PMID: 39262995 PMC: 11389545. DOI: 10.1016/j.heliyon.2024.e34385.


Decreased miR-329-3p upregulates and in mouse hepatic I/R injury in an age-independent manner.

Zhu L, Duan W, Yang B, Wang L Int J Med Sci. 2023; 20(12):1562-1569.

PMID: 37859693 PMC: 10583182. DOI: 10.7150/ijms.87174.


Non-coding RNAs: The potential biomarker or therapeutic target in hepatic ischemia-reperfusion injury.

Shao J, Wang L, Xiao J, Yang J World J Gastroenterol. 2023; 29(33):4927-4941.

PMID: 37731999 PMC: 10507504. DOI: 10.3748/wjg.v29.i33.4927.


Circ_0003747 promotes thyroid cancer progression by sponging miR-338-3p to upregulate PLCD3 expression.

Dou X, Xia F, Li X Epigenetics. 2023; 18(1):2210339.

PMID: 37166441 PMC: 10177672. DOI: 10.1080/15592294.2023.2210339.


Circ_0001052 promotes cardiac hypertrophy via elevating Hipk3.

Yang M, Wang W, Wang L, Li Y Aging (Albany NY). 2023; 15(4):1025-1038.

PMID: 36800233 PMC: 10008499. DOI: 10.18632/aging.204521.


References
1.
Lentsch A, Kato A, Yoshidome H, McMasters K, Edwards M . Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology. 2000; 32(2):169-73. DOI: 10.1053/jhep.2000.9323. View

2.
Ireton R, Chen J . EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics. Curr Cancer Drug Targets. 2005; 5(3):149-57. DOI: 10.2174/1568009053765780. View

3.
Boros P, Bromberg J . New cellular and molecular immune pathways in ischemia/reperfusion injury. Am J Transplant. 2006; 6(4):652-8. DOI: 10.1111/j.1600-6143.2005.01228.x. View

4.
Jaeschke H, Bautista A, Spolarics Z, SPITZER J . Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free Radic Res Commun. 1991; 15(5):277-84. DOI: 10.3109/10715769109105223. View

5.
Rehni A, Singh N . Role of phosphoinositide 3-kinase in ischemic postconditioning-induced attenuation of cerebral ischemia-evoked behavioral deficits in mice. Pharmacol Rep. 2007; 59(2):192-8. View